MGMT and glioblastoma: For example, the CATNON trial found no benefit of combined TMZ and radiotherapy versus radiotherapy alone in glioblastoma, IDH wild type patients, and while MGMT methylation status was predictive of patient survival it did not predict response to TMZ [20].